These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8104465)
21. Application of SERS spectroscopy to the identification of (3,4-methylenedioxy)amphetamine in forensic samples utilizing matrix stabilized silver halides. Sägmüller B; Schwarze B; Brehm G; Schneider S Analyst; 2001 Nov; 126(11):2066-71. PubMed ID: 11763093 [TBL] [Abstract][Full Text] [Related]
22. Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in The Netherlands. van Deursen MM; Lock ER; Poortman-van der Meere AJ Sci Justice; 2006; 46(3):135-52. PubMed ID: 17388242 [TBL] [Abstract][Full Text] [Related]
23. [Mass spectrometry data of some metabolites of the amphetamine derivatives 3,4-(methylenedioxy) amphetamine (MDA) and 3,4-methylenedioxy)methylamphetamine (MDMA)]. Verweij AM Arch Kriminol; 1996; 197(1-2):27-30. PubMed ID: 8851250 [TBL] [Abstract][Full Text] [Related]
24. Ion trap mass spectrometry for the characterization of N-methyl-1- (3,4-methylene-dioxyphenyl)-2-butanamine and N-ethyl-3,4- methylenedioxyamphetamine, two widely distributed street drugs. Garofano L; Santoro M; Patri P; Guidugli F; Bollani T; Favretto D; Traldi P Rapid Commun Mass Spectrom; 1998; 12(12):779-82. PubMed ID: 9650303 [TBL] [Abstract][Full Text] [Related]
25. Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) synthesised from catechol. Heather E; Shimmon R; McDonagh AM Forensic Sci Int; 2015 Mar; 248():140-7. PubMed ID: 25617761 [TBL] [Abstract][Full Text] [Related]
26. The variability of ecstasy tablets composition in Brazil. Togni LR; Lanaro R; Resende RR; Costa JL J Forensic Sci; 2015 Jan; 60(1):147-51. PubMed ID: 25125149 [TBL] [Abstract][Full Text] [Related]
27. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA. Peters FT; Samyn N; Lamers CT; Riedel WJ; Kraemer T; de Boeck G; Maurer HH Clin Chem; 2005 Oct; 51(10):1811-22. PubMed ID: 16099938 [TBL] [Abstract][Full Text] [Related]
28. Chiral separation of 3,4-methylenedioxymeth- amphetamine and related compounds in clandestine tablets and urine samples by capillary electrophoresis/fluorescence spectroscopy. Huang YS; Liu JT; Lin LC; Lin CH Electrophoresis; 2003 Mar; 24(6):1097-104. PubMed ID: 12658701 [TBL] [Abstract][Full Text] [Related]
29. [Contaminants in illegal amphetamine. Basic contaminants in drug market 3,4-(methylenedioxy)methylamphetamine]. Verweij AM Arch Kriminol; 1991; 188(5-6):154-8. PubMed ID: 1686826 [TBL] [Abstract][Full Text] [Related]
30. High-pressure liquid chromatography/electrochemical detection method for monitoring MDA and MDMA in whole blood and other biological tissues. Michel RE; Rege AB; George WJ J Neurosci Methods; 1993 Oct; 50(1):61-6. PubMed ID: 7903993 [TBL] [Abstract][Full Text] [Related]
31. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong. Cheng WC; Poon NL; Chan MF J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267 [TBL] [Abstract][Full Text] [Related]
32. High performance liquid chromatographic assays of the illicit designer drug "Ecstasy", a modified amphetamine, with applications to stability, partitioning and plasma protein binding. Garrett ER; Seyda K; Marroum P Acta Pharm Nord; 1991; 3(1):9-14. PubMed ID: 1677250 [TBL] [Abstract][Full Text] [Related]
33. Supported liquid-liquid extraction of the active ingredient (3,4-methylenedioxymethylamphetamine) from ecstasy tablets for isotopic analysis. de Korompay A; Hill JC; Carter JF; NicDaeid N; Sleeman R J Chromatogr A; 2008 Jan; 1178(1-2):1-8. PubMed ID: 18070626 [TBL] [Abstract][Full Text] [Related]
34. Establishing the synthetic origin of amphetamines by 2H NMR spectroscopy. Armellin S; Brenna E; Fronza G; Fuganti C; Pinciroli M; Serra S Analyst; 2004 Feb; 129(2):130-3. PubMed ID: 14752555 [TBL] [Abstract][Full Text] [Related]
35. An exploration of the history and controversies surrounding MDMA and MDA. Pentney AR J Psychoactive Drugs; 2001; 33(3):213-21. PubMed ID: 11718314 [TBL] [Abstract][Full Text] [Related]
36. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). Kalasinsky KS; Hugel J; Kish SJ J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119 [TBL] [Abstract][Full Text] [Related]
37. Rapid, simple, and highly sensitive analysis of drugs in biological samples using thin-layer chromatography coupled with matrix-assisted laser desorption/ionization mass spectrometry. Kuwayama K; Tsujikawa K; Miyaguchi H; Kanamori T; Iwata YT; Inoue H Anal Bioanal Chem; 2012 Jan; 402(3):1257-67. PubMed ID: 22147272 [TBL] [Abstract][Full Text] [Related]
38. Adam and Eve make love. Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, "Eve") and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain. Tucker G Hum Exp Toxicol; 1996 May; 15(5):455-7. PubMed ID: 8735473 [No Abstract] [Full Text] [Related]
39. Simultaneous determination of HFBA-derivatized amphetamines and ketamines in urine by gas chromatography-mass spectrometry. Lee HH; Lee JF; Lin SY; Chen PH; Chen BH J Anal Toxicol; 2011 Apr; 35(3):162-9. PubMed ID: 21439152 [TBL] [Abstract][Full Text] [Related]
40. Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB, MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe. Liu C; Jia W; Qian Z; Li T; Hua Z Drug Test Anal; 2017 Feb; 9(2):199-207. PubMed ID: 26856255 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]